ArticleOpen forum infectious diseases2019

Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface Antigens.

Emanuela Zappulo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.